D
Madrigal Pharmaceuticals, Inc. MDGL
$423.24 $11.012.67% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 44.77% 11.86% -24.69% -49.33% -54.78%
Total Depreciation and Amortization 114.61% 138.70% 107.97% 70.23% 42.40%
Total Amortization of Deferred Charges -30.74% -29.06% -13.46% 19.98% 59.03%
Total Other Non-Cash Items 14.46% 37.89% 59.81% 78.28% 86.89%
Change in Net Operating Assets -716.72% -1,217.35% -2,108.33% 952.56% -210.48%
Cash from Operations 31.53% -1.54% -40.51% -42.34% -62.10%
Capital Expenditure 47.72% 38.65% 1.15% -387.92% -1,022.29%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 88.74% 3.87% 45.53% -697.22% -467.19%
Cash from Investing 88.51% 4.16% 45.40% -695.24% -468.74%
Total Debt Issued -- -- -- -100.00% -70.00%
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -96.85% -84.35% 38.57% 279.55% 284.34%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 100.00% 73.96%
Cash from Financing -96.88% -84.77% 23.52% 214.91% 235.41%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -173.01% -185.20% 102.20% 6,368.84% 1,665.60%